Status:
ENROLLING_BY_INVITATION
The Effect of Asthma Flare-up Clinic After Exacerbation
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Collaborating Sponsors:
AstraZeneca
Conditions:
Asthma
Asthma Attack
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The goal of this interventional study is to examine the effect of asthma flare-up clinic follow-up in adult subjects after an asthma flare-up. This study aim to answer the following questions: 1. Doe...
Detailed Description
The primary outcomes will be analyzed as total exacerbations during the time frame and as a time-dependent variable (time to exacerbation) using Kaplan Meier survival analysis. Additional sub-analyses...
Eligibility Criteria
Inclusion
- Prior asthma diagnosis based on clinical and spirometry accepted criteria.
- Acute exacerbation of asthma as the main reason for ED arrival.
- Ability to perform in-person and telephone follow-up.
- Agree to participate, with a signed or verbal informed consent, according to the study group.
Exclusion
- Uncontrolled comorbidity.
- Cognitive dysfunction.
- Patients under 18 years or above 75 years.
- Chronic obstructive pulmonary disease (COPD) or other lung diseases (eg, idiopathic pulmonary fibrosis, Churg-Strauss Syndrome, etc) which may impair lung function.
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT06201728
Start Date
May 1 2024
End Date
September 1 2026
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel